Article Text

Download PDFPDF
CASE REPORT
Rare cause for a common presentation: isolated pulmonary valve endocarditis yet another mimicker
  1. Ahmed Shameem Reza1,
  2. Dharmesh Anand2,
  3. Sing Huey Cheng3,
  4. Dharampal Anand3
  1. 1Department of Cardiology, Western Health, Melbourne, Victoria, Australia
  2. 2Department of Cardiology, The Townsville Hospital, Townsville, Australia
  3. 3Department of Medicine, The Townsville Hospital, Townsville, Australia
  1. Correspondence to Dr Ahmed Shameem Reza, sreza53{at}gmail.com

Summary

Isolated pulmonary valve endocarditis (PVE) is a rare condition. Known risk factors in previous case reports were intravenous drug abuse and congenital heart disease. Epidemiology of PVE has been changing. It is now being reported specially following invasive healthcare-related procedures even in patients with structurally normal heart. Vast majority of patients present with respiratory symptoms and diagnosis of endocarditis may be challenging unless there is high index of suspicion. Various microorganisms had been isolated as aetiological agents; however, Enterococcus faecalis is being increasingly isolated. PVE mostly managed conservatively with intravenous antibiotics with option for surgical intervention in specific situations. We present a patient with isolated PVE due to E. faecalis following colonoscopy and polypectomy with predisposing risk factor of alcohol excess, mimicking clinically as pneumonia and radiologically as a neoplastic lesion.

  • nosocomial infections
  • valvar diseases

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Footnotes

  • Contributors ASR was involved in the concept and design of the work, drafting the article, corrections, data collection, analysis, literature review and overall coordination. DA was responsible for the conception, data acquisition of TOE, follow-up review and revising the paper critically. SHC and DA were responsible for the conception, data acquisition and review. SHC was also responsible for the consent taking. All authors contributed to the final approval of the paper and agreed to be accountable.

  • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

  • Competing interests None declared.

  • Patient consent Obtained.

  • Provenance and peer review Not commissioned; externally peer reviewed.